Material Safety Data Sheet PERMETHOR* Insecticidal Dust Section 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY This product is NOT classified as Hazardous according to the criteria of NOHSC Australia. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. Substance:
Ready to use powder-based insecticide containing permethrin. Trade Name: Permethor Insecticidal Dust. Product Use: Insecticide for use as described on the product label. Creation Date: October, 2004 Reviewed on: 16 March 2011 Section 2 - HAZARDS IDENTIFICATION Statement of Hazardous Nature This product is NOT classified as hazardous according to the criteria of NOHSC Australia. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. Safety Phrases: SUSDP Classification: ADG Classification:
None allocated. Not a Dangerous Good. UN Number: Emergency Overview Physical Description & colour: Off-white powder. Odour: Negligible. Major Health Hazards: Permethrin is harmful to non-harmful via the oral route, with a reported LD50 for technical
permethrin in rats of over 5000 mg/kg. Via the dermal route, it is not harmful, with a reported dermal LD50 in rats of
over 5000 mg/kg, and in rabbits of greater 2000 mg/kg. Potential Health Effects See section 11 for Chronic exposure studies. Inhalation: Short term exposure: Available data indicates that this product is not harmful. Skin Contact: Short term exposure: Product is not harmful. May cause mild transient discomfort in sensitive persons. Eye Contact: Short term exposure: This product is unlikely to cause anything more than mild transient discomfort. Ingestion: Short term exposure: This product is unlikely to cause any irritation problems in the short or long term. Carcinogen Status: NOHSC: No significant ingredient is classified as carcinogenic by NOHSC.
No significant ingredient is classified as carcinogenic by NTP.
Permethrin is Class 3 - unclassifiable as to carcinogenicity to humans. Section 3 - COMPOSITION/INFORMATION ON INGREDIENTS Ingredients TWA (mg/m3) STEL (mg/m3)
This is a commercial product whose exact ratio of components may vary slightly. Section 4 - FIRST AID MEASURES General Information: You should call The Poisons Information Centre if you feel that you may have been poisoned or irritated by this product. The number is 13 11 26 from anywhere in Australia (0800 764 766 in New Zealand) and is available at all times. Inhalation: No first aid measures normally required. However, if inhalation has occurred, and irritation has developed, remove to fresh air and observe until recovered. If irritation becomes painful or persists more than about 30 minutes, seek medical advice. Skin Contact: Not considered harmful. If significant skin contact occurs, wash gently and thoroughly with water (use
non-abrasive soap if necessary) for 5 minutes or until product is removed. Eye Contact: Gently blot or brush product away. Flush contaminated eye(s) with lukewarm, gently flowing water until the product is removed, while holding the eyelid(s) open. Obtain medical advice if irritation becomes painful or lasts more than a few minutes. Ingestion: First aid is not generally required. If in doubt, contact a Poisons Information Centre or a doctor. Section 5 - FIRE FIGHTING MEASURES Fire and Explosion Hazards: There is no risk of an explosion from this product under normal circumstances if it is involved in a fire. Only small quantities of decomposition products are expected from this products at temperatures
normally achieved in a fire. Fire decomposition products from this product may be toxic if inhaled. Take appropriateprotective measures. Extinguishing Media: Not Combustible. Use extinguishing media suited to burning materials. Flash point: Upper Flammability Limit: Does not burn. Lower Flammability Limit: Does not burn. Autoignition temperature: Does not burn. Flammability Class: Section 6 - ACCIDENTAL RELEASE MEASURES Accidental release: Minor spills do not normally need any special clean-up measures. In the event of a major spill,
prevent spillage from entering drains or water courses. Wear protective clothing including face shield and gloves. Seeabove under Personal Protection regarding Australian Standards relating to personal protective equipment. Stop leakand contain spill. Sweep up and shovel or collect recoverable product into labelled containers for recycling or salvage, and dispose ofpromptly. Consider vacuuming if appropriate. Recycle containers wherever possible after careful cleaning. After spills,wash area preventing run-off from entering drains. If a significant quantity of material enters drains, advise emergencyservices. This material may be suitable for approved landfill. Ensure legality of disposal by consulting regulations prior
to disposal. Launder clothing before storage or re-use. Section 7 - HANDLING AND STORAGE Handling: Keep exposure to a minimum, and minimise the quantities kept in work areas. Check Section 8 of this MSDS for details of personal protective measures, and make sure that those measures are followed. Storage: Store in the closed original container in a dry, cool, well-ventilated area out of direct sunlight. Check packaging - there may be further storage instructions on the label. Section 8 - EXPOSURE CONTROLS AND PERSONAL PROTECTION
The following Australian Standards will provide general advice regarding safety clothing and equipment: Respiratory equipment: AS/NZS 1715, Protective Gloves: AS 2161, Industrial Clothing: AS2919, Industrial Eye
Protection: AS1336 and AS/NZS 1337, Occupational Protective Footwear: AS/NZS2210. Exposure Limits Exposure limits have not been established by NOHSC for any of the significant ingredients in this product.
The ADI for permethrin is set at 0.05mg/kg/day. The corresponding NOEL is set at 5mg/kg/day. ADI means Acceptable
Daily Intake and NOEL means No-observable-effect-level. Values taken from Australian ADI List, Dec 2002. Ventilation:
No special ventilation requirements are normally necessary for this product. Eye Protection: Eye protection such as protective glasses is recommended when product is being used. Skin Protection: Minimise skin contact by wearing gloves and overalls. Respirator: Section 9 - PHYSICAL AND CHEMICAL PROPERTIES Physical Description & colour: Boiling Point: Freezing/Melting Point: Volatiles:
No specific data. Expected to be low at 100°C. Water Solubility: Autoignition temp: Section 10 - STABILITY AND REACTIVITY Reactivity: This product is unlikely to react or decompose under normal storage conditions. However, if you have any doubts, contact the supplier for advice on shelf life properties. Conditions to Avoid: Store in the closed original container in a dry, ventilated area out of direct sunlight. Incompatibilities: No particular incompatibilities. Fire Decomposition: Only small quantities of decomposition products are expected at temperatures normally achieved in a fire. Carbon dioxide, and if combustion is incomplete, carbon monoxide and smoke. Polymerisation: This product is unlikely to undergo polymerisation processes. Section 11 - TOXICOLOGICAL INFORMATION Toxicity: Acute toxicity: Permethrin is harmful to non-harmful via the oral route, with a reported LD50 for technical
permethrin in rats of greater than 5000 mg/kg. Via the dermal route, it is not harmful, with a reported dermal LD50 in
rats of over 5000 mg/kg, and in rabbits of greater 2000 mg/kg. The toxicity of permethrin is dependent on the ratio ofthe isomers present; the cis-isomer being more toxic. Chronic toxicity: No adverse effects were observed in dogs fed permethrin at doses of 5 mg/kg/day for 90 days. Rats fed 150 mg/kg/day for 6 months showed a slight increase in liver weights. Very low levels of permethrin in the diet of chickens (0.1 ppm for 3 to 6 weeks after hatching) have been reported to suppress immune system activity. Teratogenic effects: Permethrin is reported to show no teratogenic activity. Mutagenic effects: Permethrin is reported to show no mutagenic activity. Carcinogenic effects: None reported. Fate in humans and animals: Permethrin is efficiently metabolized by mammalian livers. Breakdown products, or
"metabolites," of permethrin are quickly excreted and do not persist significantly in body tissues. When permethrin isadministered orally to rats, it is rapidly metabolized and almost completely eliminated from the body in a few days. Only 3 to 6% of the original dose was excreted unchanged in the faeces of experimental animals. Permethrin maypersist in fatty tissues. Permethrin does not block, or inhibit, cholinesterase enzymes. Section 12 - ECOLOGICAL INFORMATION Effects on birds: Permethrin is practically non-toxic to birds. The oral LD50 for a permethrin formulation is greater than
9900 mg/kg in mallard ducks, greater than 13,500 mg/kg in pheasants, and greater than 15,500 mg/kg in quail. Effects on aquatic organisms: Aquatic ecosystems are vulnerable to the impact of permethrin. Effects on other organisms: Permethrin is toxic to bees. Environmental Fate: Breakdown in soil and groundwater: Permethrin is of low to moderate persistence in the soil environment, with reported half-lives of 30 to 38 days. Permethrin is readily broken down, or degraded, in most soils. Soil micro- organisms play a large role in the degradation of permethrin. Because permethrin binds very strongly to soil particles
and is nearly insoluble in water, it is not expected to leach or to contaminate groundwater. Breakdown in water: The results of one study near estuarine areas showed that permethrin had a half-life of less than 2.5 days. When exposed to sunlight, the half-life was 4.6 days. Permethrin degrades rapidly in water. There was a gradual loss of toxicity after it aged for 48 hours in sunlight at 0.05 mg/L in water. Breakdown in vegetation: Permethrin is not phytotoxic, or poisonous, to most plants. No incompatibility has been observed with permethrin on cultivated plants. Section 13 - DISPOSAL CONSIDERATIONS Disposal: Instructions concerning the disposal of this product and its containers are given on the product label. These should be carefully followed. Section 14 - TRANSPORT INFORMATION ADG Code: This product is not a Dangerous Good. No special transport conditions necessary. Section 15 - REGULATORY INFORMATION AICS: All of the significant ingredients in this formulation are to be found in the public AICS Database. Section 16 - OTHER INFORMATION This MSDS contains only safety-related information. For other data see product literature. Acronyms: ADG Code
Australian Code for the Transport of Dangerous Goods by Road and Rail
Australian Inventory of Chemical Substances
CAS number
Chemical Abstracts Service Registry Number
Hazchem Number
Emergency action code of numbers and letters that provide information to emergencyservices especial y fire-fighters
International Agency for Research on Cancer
National Occupational Health and Safety Commission
R-Phrase
Standard for the Uniform Scheduling of Drugs & Poisons
UN Number
This MSDS summarises our best knowledge of the health and safety hazard information of the product and how to safely handleand use the product in the workplace. Each user must review this MSDS in the context of how the product wil be handled and used
in the workplace. If clarification or further information is needed to ensure that an appropriate risk assessment can be made, the user should contact
Ensystex so we can attempt to obtain additional information from our suppliersOur responsibility for products sold is subject to our standard terms and conditions, a copy of which is sent to our customers and isalso available on request.
Please read all labels careful y before using product.
WHO WE ARE; On Being (and Not Being) A Jewish American Writer Roxana Mihele WHO WE ARE; On Being (and Not Being) A Jewish American Writer is a collection of twenty-nine essays edited by Derek Rubin and published in 2005 by Schocken Books, New York. The essays were written after the Second World War on different occasions by the major Jewish American writers such as: Saul Bellow, Gr
Competition - Switzerland Secretariat of Competition Commission Finds Vertical Collusion in Viagra Market On February 10 2009 the Secretariat of the Competition Commission issued a decisionproposal to charge the manufacturers and distributors of male impotence drugs with price fixing. Following an investigation opened in 2006 into prices charged for erectile dysfunction medication (